Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Type I intestinal lymphangiectasia treated successfully with slow-release octreotide.

Literature DB >> 12924644

Type I intestinal lymphangiectasia treated successfully with slow-release octreotide.

R D Klingenberg¹, N Homann, D Ludwig.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2003 PMID： 12924644 DOI： 10.1023/a:1024707605493

Source DB: PubMed Journal: Dig Dis Sci ISSN： 0163-2116 Impact factor: 3.199

× No keyword cloud information.

14 in total

1. Mesenteric blood flow is related to disease activity and risk of relapse in ulcerative colitis: a prospective follow up study.

Authors: D Ludwig; S Wiener; A Brüning; K Schwarting; G Jantschek; K Fellermann; M Stahl; E F Stange
Journal: Gut Date: 1999-10 Impact factor: 23.059

2. Stable reversal of pathologic signs of primitive intestinal lymphangiectasia with a hypolipidic, MCT-enriched diet.

Authors: V Alfano; G Tritto; L Alfonsi; A Cella; F Pasanisi; F Contaldo
Journal: Nutrition Date: 2000-04 Impact factor: 4.008

3. LOW-FAT DIET IN INTESTINAL LYMPHANGIECTASIA. ITS EFFECT ON ALBUMIN METABOLISM.

Authors: G H JEFFRIES; A CHAPMAN; M H SLEISENGER
Journal: N Engl J Med Date: 1964-04-09 Impact factor: 91.245

4. Reduction of lymphorrhagia from ruptured thoracic duct by somatostatin.

Authors: J I Ulíbarri; Y Sanz; C Fuentes; A Mancha; M Aramendia; S Sánchez
Journal: Lancet Date: 1990-07-28 Impact factor: 79.321

5. Octreotide for protein-losing enteropathy with intestinal lymphangiectasia.

Authors: D J Bac; P M Van Hagen; P T Postema; A M ten Bokum; P E Zondervan; M van Blankenstein
Journal: Lancet Date: 1995-06-24 Impact factor: 79.321

6. Mesenteric blood flow is related to disease activity and risk of relapse in Crohn's disease: a prospective follow-up study.

Authors: D Ludwig; S Wiener; A Brüning; K Schwarting; G Jantschek; E F Stange
Journal: Am J Gastroenterol Date: 1999-10 Impact factor: 10.864

7. Long-term haemodynamic effects of octreotide on postprandial splanchnic hyperemia in humans: a placebo-controlled echo-doppler study.

Authors: D Ludwig; S Terai; A Brüning; E F Stange
Journal: Aliment Pharmacol Ther Date: 1999-08 Impact factor: 8.171

8. Intestinal lymphangiectasia. Long-term results with MCT diet.

Authors: W L Tift; J K Lloyd
Journal: Arch Dis Child Date: 1975-04 Impact factor: 3.791

9. Superior mesenteric artery blood flow in man measured with intra-arterial Doppler catheters: effect of octreotide.

Authors: P A McCormick; A M Seifalian; G Stansby; G McGann; P Collins; J Chin; N McIntyre; R Dick; A K Burroughs
Journal: J Hepatol Date: 1993-01 Impact factor: 25.083

10. Fibrotic entrapment of the small bowel in congenital intestinal lymphangiectasia.

Authors: C Rust; E Pratschke; W Hartl; M Kessler; B Weibecke; T Sauerbruch; G Paumgartner; U Beuers
Journal: Am J Gastroenterol Date: 1998-10 Impact factor: 10.864

11 in total

1. Intestinal lymphangiectasia in adults.

Authors: Hugh James Freeman; Michael Nimmo
Journal: World J Gastrointest Oncol Date: 2011-02-15

2. Anaemia in Waldmann's disease: A rare presentation of a rare disease.

Authors: Shahira A El-Etreby; Ahmed Y Altonbary; Mohamed El Sorogy; Wagdi Elkashef; Jehan A Mazroa; Monir H Bahgat
Journal: World J Gastrointest Endosc Date: 2015-05-16

Review 3. Primary intestinal lymphangiectasia: four case reports and a review of the literature.

Authors: Jie Wen; Qingya Tang; Jiang Wu; Ying Wang; Wei Cai
Journal: Dig Dis Sci Date: 2010-03-03 Impact factor: 3.199

4. Complicated primary intestinal lymphangiectasia (Waldmann's disease) in a child successfully treated with octreotide: A case report from a low-resource setting.

Authors: Zohair El Haddar; Yassine Sbia; Maria Rkain; Noufissa Benajiba; Abdeladim Babakhouya
Journal: Ann Med Surg (Lond) Date: 2021-07-29